[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-365915-105":59,"doc-detail-365915-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","stk32c-promotes-colon-tumor-progression-through-activating-c-myc-signaling","STK32C promotes colon tumor progression through activating c-MYC signaling","","Serine/threonine kinase 32C (STK32C) is evaluated as a driver of colorectal cancer (CRC) progression with emphasis on its control of MYC signaling. CRC sample analysis and cell experiments show STK32C is markedly upregulated in tumor tissues and links to unfavorable prognosis. Functional assays demonstrate that STK32C enhances CRC proliferation, migration, and invasion, likely via MYC phosphorylation at S420 that stabilizes MYC and boosts signaling. Mouse xenografts confirm that STK32C knockdown reduces tumor growth and MYC pathway activation, supporting STK32C as a potential CRC therapeutic target.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/stk32c-promotes-colon-tumor-progression-through-activating-c-myc-signaling/365915/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/stk32c-promotes-colon-tumor-progression-through-activating-c-myc-signaling/365915.png","ImageObject",300,407,{"name":92,"@type":93},"Angel","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-02","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What role does STK32C play in colorectal cancer progression?","Question",{"text":113,"@type":114},"STK32C expression is elevated in colorectal cancer tissues and is associated with poor prognosis. Experimental results show it promotes CRC proliferation, migration, and invasion.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does STK32C affect the MYC signaling pathway?",{"text":118,"@type":114},"STK32C is reported to promote CRC progression by phosphorylating MYC at the S420 site, which enhances MYC stability and signaling activity.",{"name":120,"@type":111,"acceptedAnswer":121},"What do in vivo experiments show after STK32C knockdown?",{"text":122,"@type":114},"In a mouse xenograft model, STK32C knockdown suppresses tumor growth and reduces activation of the MYC pathway.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},365915,1790194670,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":36,"preview_page_count":19,"preview_urls":146},687207412472,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Cellular and Molecular Life Sciences (2025) 82:235  \n[https://doi.org/10.1007/s00018-025-05773-y](https://doi.org/10.1007/s00018-025-05773-y) Cellular and Molecular Life Sciences  \nORIGINAL ARTICLE  \nSTK32C promotes colon tumor progression through activating c-MYC signaling  \nXin Zhang1 · Mingxin Jin1 · Yali Chu1 · Fengjun Liu1 · Hui Qu1 · Cheng Chen1  \nReceived: 6 January 2025 / Revised: 21 May 2025 / Accepted: 28 May 2025 © The Author(s) 2025  \nAbstract  \nSerine/threonine kinase 32C (STK32C) is a member of the AGC kinase family and has been identified as a potential promoter of cancer progression, though its role remains largely uncharacterized. This study explores the impact of STK32Con colorectal cancer (CRC) progression, particularly focusing on its influence on the MYC signaling pathway. Analysis of CRC samples and in vitro experiments revealed that STK32C expression is significantly elevated in cancerous tissues and associated with poor prognosis. Functional assays demonstrated that STK32C promotes proliferation, migration, and invasion of CRC cells, likely through phosphorylation of MYC at the S420 site, enhancing MYC stability and signaling activity. In vivo studies using a mouse xenograft model confirmed that STK32C knockdown suppresses tumor growth and MYC pathway activation. These findings suggest that STK32C contributes to CRC progression by modulating MYC signaling, highlighting its potential as a therapeutic target in CRC.  \nKeywords STK32C · Colorectal cancer · MYC signaling pathway  \nIntroduction  \nColorectal cancer (CRC) remains a leading cause of cancerrelated deaths worldwide, largely due to its high rates of metastasis and recurrence. Understanding the molecular mechanisms driving CRC progression is critical to identifying new therapeutic targets [1–3]. Among the genes implicated in cancer, MYC is one of the most extensively studied oncogenes [4, 5] . As a transcription factor, MYC regulatesa vast array of cellular processes, including cell proliferation, differentiation, metabolism, and apoptosis [6–9] . It is estimated that MYC controls the expression of 15% of the human genome, making it a\"master regulator\"of gene expression [10–16] . Dysregulation of MYC occurs in up to 70% of human cancers [17, 18], underscoring its importance  \n􀀍 Cheng Chen [cc_089@126.com](cc_089@126.com)  \n1 Department of General Surgery, Qilu Hospital of Shandong University, 107 West Wenhua Road, JiNan 250012, China  \nin tumor biology and the potential value of targeting MYCrelated pathways in cancer therapy [19] .  \nSTK32C (Serine/Threonine Kinase 32 C) belongs to the YANK subfamily of the AGC kinase family, which also includes STK32A (YANK1) and STK32B (YANK2) . These kinases are evolutionarily conserved in fungi and animals, though they have been lost in certain lineages, such as Saccharomyces cerevisiae. Structurally, YANK kinases contain an AGC kinase domain and a divergent AGC tail that retainsa regulatory hydrophobic motif, which plays a crucial role in their activation and substrate recognition. [20] Studies suggest its overexpression in brain tissue may be linked to adolescent depression, based on DNA methylation differences in monozygotic twins [21] . Additional findings link STK32C with CD4 + regulatory T cell activity, pulmonary inflammation, and upregulated expression in several cancers, including prostate cancer and bladder cancer [22–25] . However, its biological function is still unclear in colorectal cancer.  \nIn this study, we focused on STK32C’s role in CRC. Our data revealed that STK32C was highly expressed in CRC tissues and was associated with worse survival outcomes. Through in vitro and in vivo experiments, we investigated  \n1 3  \nthe mechanisms underlying STK32C's role in CRC progression. We demonstrated that STK32C overexpression enhanced CRC cell proliferation, migration, and invasion, likely through phosphorylation of MYC at the S420 site, which stabilized MYC and activated downstream signaling pathways","cbCaisqwROXIq8zs","https://ap.wps.com/l/cbCaisqwROXIq8zs","pdf",15130742,16,"English","# Abstract\n## Introduction\n## Material and methods\n## Reagents and antibodies\n## Cell culture and treatment\n## Cell viability assay\n## BrdU assay","[{\"question\":\"What role does STK32C play in colorectal cancer progression?\",\"answer\":\"STK32C expression is elevated in colorectal cancer tissues and is associated with poor prognosis. Experimental results show it promotes CRC proliferation, migration, and invasion.\"},{\"question\":\"How does STK32C affect the MYC signaling pathway?\",\"answer\":\"STK32C is reported to promote CRC progression by phosphorylating MYC at the S420 site, which enhances MYC stability and signaling activity.\"},{\"question\":\"What do in vivo experiments show after STK32C knockdown?\",\"answer\":\"In a mouse xenograft model, STK32C knockdown suppresses tumor growth and reduces activation of the MYC pathway.\"}]","STK32C promotes colon tumor progression through activating c-MYC signaling | PDF",1790162918,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/68d36f946fdf93ab1bab2f6ca4e3de68.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0893db786bcc69e7373b65cf7d22856c.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fcbe8a91cec9f51583e8cf30dc83022a.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3c2c80650fe84585b868958d65eae7cb.webp",980,1301]